MAPT and Alzheimer disease: AsymAD cases exhibited neuropathologically comparable levels of Aβ plaques and tau tangles to AD cases but lacked significant cognitive impairment near the time of death, which is inferred to be an indicator of early preclinical stages of AD [48].